Browse by author
Lookup NU author(s): Dr Stuart Watson, Professor Allan Young
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
This article reviews the evidence supporting different somatic treatment strategies in the acute and maintenance treatment phases of bipolar disorder. Bipolar affective disorder is a chronic disorder with a life time incidence of 0.3 - 1.5/100 [1]. Severe affective disorder is associated with a risk of completed suicide of 6 - 15% [2,3]. Traditionally, bipolar disorder has been considered as an episodic disorder with good inter-episode recovery [4]. This is being increasingly challenged with patients demonstrating social, marital, occupational and cognitive dysfunction, even when euthymic [5]. The management of bipolar disorder should be considered in the context of; the type of episode, this may be manic, depressed or mixed; the degree and rate of recovery; the cycling frequency and precipitant, if any, for recurrence and the onset and evolution of the underlying illness. On average, four episodes occur every 10 years. However 13 - 24% of patients develop rapid cycling disorder, in which four or more episodes occur within a year. Patients with bipolar disorder often have co-morbid anxiety and substance abuse. Moreover, axis I co-morbidity may be associated with an earlier age at onset and worsening course of bipolar illness. [6]. Axis II co-morbidity is also common, this was highlighted in a study by Kay and colleagues who, after excluding patients with a history of alcohol misuse, demonstrated axis II co-morbidity in almost a quarter of euthymic bipolar patients [7]. Good practice relies on an overall management plan that incorporates somatic, psychological and social approaches. This paper will focus on one element of such a plan, the currently available somatic management strategies for bipolar disorder.
Author(s): Watson S; Young AH
Publication type: Review
Publication status: Published
Journal: Expert Opinion on Pharmacotherapy
Year: 2001
Volume: 2
Issue: 4
Pages: 601-612
Print publication date: 01/01/2001
ISSN (print): 1465-6566
ISSN (electronic): 1744-7666
URL: http://dx.doi.org/10.1517/14656566.2.4.601
DOI: 10.1517/14656566.2.4.601
PubMed id: 11336610